Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co extends med ed portal to India

Pharma company makes Univadis accessible to yet more healthcare professionals
Merck Univadis India

India has become the latest in more than 40 countries to have access to Univadis, a healthcare education and information produced by Merck & Co.

The website, launched in 2001, is free to healthcare professionals and has been developed in conjunction with London-based medical publication The Lancet. It gives users access to exclusive content such as articles, news, research papers, videos and other educational tools.

"We are launching a unique online medical education service to aid comprehensive healthcare management, making available unbiased, reliable scientific medical information," said KG Ananthakrishnan, managing director of Merck's Indian subsidiary MSD Pharmaceuticals Pvt.

“This unique medical education service to support comprehensive healthcare management will provide Indian doctors with updated information to expand their knowledge and expertise”.

It is hoped that Merck's move will help health professions in India, where providing continued medical education for doctors remains challenging.

At present, Indian doctors' medical knowledge is either not updated frequently enough or they find themselves dependent on sponsored conferences for their ongoing education and access to news of industry developments.

“Our partnership with Univadis offers a unique opportunity to increase delivery of the best science to Indian doctors in free and easily accessible format,” added David Collingridge, publishing director for Lancet specialty journals.

Article by
Tara Craig

1st July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Indigenus

A global healthcare communications network dedicated to helping clients grow their brands. Unstuck, with an entrepreneurial and nimble spirit....

Latest intelligence

A stumble, but not a fall – what’s next for Opdivo?
Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results....
Blog: A new 'At your service' model for pharma
Turning the traditional sales model on its head to deliver commercial outcomes without selling at all...
london-conferences-anthill.jpg
Meet Anthill at conferences in London
October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit...

Infographics